Short answer
Korro Bio, Inc. (KRRO) filed an 8-K current report with the SEC on March 12, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Full-year 2025 financial results released March 12, 2026: details in Exhibit 99.1.
Korro Bio, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Full-year 2025 financial results released March 12, 2026: details in Exhibit 99.1
- KRRO is a clinical-stage biotech; cash runway and R&D spend are key metrics to watch in the release
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Korro Bio, Inc. 8-K filings
Get the next KRRO 8-K as it lands
Follow KRRO for push alerts, or ask the research agent what this filing means.